Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

Market Cap	5.54B +38.1%
Revenue (ttm)	924.53M +34.4%
Net Income	81.67M +298.5%
EPS	0.16 +300.0%
Shares Out	499.58M
PE Ratio	69.25
Forward PE	24.62
Dividend	0.15 (1.33%)
Ex-Dividend Date	Jul 25, 2025

Volume	33,758,627
Average Volume	18,351,447
Open	10.89
Previous Close	11.25
Day's Range	10.89 - 11.52
52-Week Range	6.86 - 15.21
Beta	1.92
RSI	47.21
Earnings Date	Mar 24, 2026

About SHE:002728

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company’s products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. The company was founded in 2002 an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 1,341
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002728

Financial Performance

In 2025, SHE:002728's revenue was 924.53 million, an increase of 34.42% compared to the previous year's 687.79 million. Earnings were 81.67 million, an increase of 298.50%.